UK markets closed

Generix SA (106.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
9.66+0.08 (+0.84%)
At close: 08:01AM CEST
Full screen
Previous close9.58
Open9.66
Bid9.60 x N/A
Ask9.78 x N/A
Day's range9.66 - 9.66
52-week range5.46 - 9.68
Volume350
Avg. volume0
Market cap220.061M
Beta (5Y monthly)0.45
PE ratio (TTM)74.31
EPS (TTM)0.13
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Generix Group - Q1 2022/2023 REVENUES: €20.9M New SaaS contracts Q1 2022/2023: €1.2m Growth in SaaS revenues: 11%

    PRESS RELEASE Paris, July 26, 2022 Q1 2022/2023 REVENUES: €20.9M New SaaS contracts Q1 2022/2023: €1.2m Growth in SaaS revenues: 11% Generix Group, Industrial, Logistics and Retail Ecosystems provider with leading Collaborative SaaS Solutions, publishes today its revenues for the 2022/2023 first quarter. Q1 revenues: €20.9 million Quarter ended June 30ChangeUnaudited (K€)20222021SaaS9 0938 18611%Maintenance4 6374 6460%Licenses6301 177-46%Software revenues14 36014 0092,5%Consulting Services6 5687

  • Globe Newswire

    Provision of the draft information memorandum

    As announced on June 13, New Gen Holding SAS filed on June 15, 2022 a simplified public offer for Generix Group shares at a price of €9.50 per share, plus an additional €0.50 per share if the threshold of 90% of the share capital and voting rights is reached at the end of the offer. The project of a simplified takeover bid and the Draft Prospectus remain subject to the review of the AMF. The Draft Prospectus is available on the websites of the AMF (www.amf-france.org) and Generix Group (www.gene

  • Globe Newswire

    Acquisition of shares by New Gen Holding through contributions in kind and purchase of shares from minority financial shareholders of Generix Group

    Acquisition of shares by New Gen Holding through contributions in kind and purchase of shares from minority financial shareholders of Generix Group (GENX - FR0010501692). Paris, June 13, 2022 - Following the conclusion of an investment agreement on May 25, 2022 (the "Agreement"), between Generix Group, its main managers, including Mr. Jean-Charles Deconninck, Mrs. Aïda Collette-Sène, Mr. Ludovic Luzza and Mr. Philippe Seguin (the "Managers"), Pléiade Investissement and its managers ("Pléiade") a